Premium
Actinium Pharmaceuticals Inc (ATNM)
AMEX
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. The company offers Actimab-A, a CD33 targeting radiotherapeutic for patients with Relapsed/Refractory AML which... Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. The company offers Actimab-A, a CD33 targeting radiotherapeutic for patients with Relapsed/Refractory AML which is in to a Phase 2/3 Trial; and Iomab-ACT, to improve patient access to and outcomes with cellular therapies, such as CAR-T and gene therapies for non-malignant hematologic disorders such as sickle cell disease. It also develops ATNM-400, a antibody radioconjugate that deliver alpha-emitter Ac-225 to prostate cancer cells. In addition, the company's Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and refractory acute myeloid leukemia. Further, it engages with the National Cancer Institute under the cooperative research and development agreement for the development of Actimab-A in AML and other myeloid malignancies, and its research and development activities primarily focus on advancing various preclinical programs for solid tumor indications. The company is based in New York, New York. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.004 | -0.41067761807 | 0.974 | 1.05 | 0.9365 | 119527 | 1.00618972 | CS |
| 4 | -0.06 | -5.82524271845 | 1.03 | 1.11 | 0.9365 | 133167 | 0.99797992 | CS |
| 12 | -0.31 | -24.21875 | 1.28 | 1.5294 | 0.9365 | 172324 | 1.21414313 | CS |
| 26 | -0.46 | -32.1678321678 | 1.43 | 1.5294 | 0.9365 | 151619 | 1.18958332 | CS |
| 52 | -0.48 | -33.1034482759 | 1.45 | 1.89 | 0.9365 | 172882 | 1.39567752 | CS |
| 156 | -6.23 | -86.5277777778 | 7.2 | 10.24 | 0.9365 | 302162 | 3.23198937 | CS |
| 260 | -6.27 | -86.6022099448 | 7.24 | 15.12 | 0.9365 | 315851 | 5.46238012 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
